REAL‐WORLD TREATMENT PATTERNS AND OUTCOMES OF 3455 PREVIOUSLY UNTREATED MANTLE CELL LYMPHOMA PATIENTS IN US ROUTINE CLINICAL PRACTICE

Real-World Treatment Patterns and Outcomes in Previously Untreated Mantle Cell Lymphoma: Findings From a Retrospective Study

Default Digital Object Group ◽

10.1200/adn.21.200588 ◽

2021 ◽

Keyword(s):

Retrospective Study ◽

Mantle Cell Lymphoma ◽

Real World ◽

Cell Lymphoma ◽

Treatment Patterns ◽

MCL-113: IBRORS-MCL Study: A Spanish Retrospective and Observational Study of Relapsed/Refractory Mantle-Cell Lymphoma (MCL) Treated with Ibrutinib in Routine Clinical Practice

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/s2152-2650(20)30860-0 ◽

2020 ◽

Vol 20 ◽

pp. S258-S259

Author(s):

Juan Manuel Sancho ◽

Ana Marín ◽

Silvia Fernández ◽

Francisco Javier Capote ◽

Carolina Cañigral ◽

...

Keyword(s):

Clinical Practice ◽

Observational Study ◽

Mantle Cell Lymphoma ◽

Cell Lymphoma ◽

Evaluation of safety, tolerability and efficacy of temsirolimus in patients (pts) with relapsed or refractory mantle cell lymphoma (rel/refr MCL) in routine clinical practice

Annals of Oncology ◽

10.1093/annonc/mdy286.008 ◽

2018 ◽

Vol 29 ◽

pp. viii362

Author(s):

M.H. Dreyling ◽

G. Hess ◽

M. Woike ◽

G. Krekeler

Keyword(s):

Clinical Practice ◽

Mantle Cell Lymphoma ◽

Cell Lymphoma ◽

Evaluation of safety, tolerability and efficacy of temsirolimus in patients (pts) with relapsed or refractory mantle cell lymphoma (rel/refr MCL) in routine clinical practice

Annals of Oncology ◽

10.1093/annonc/mdw375.25 ◽

2016 ◽

Vol 27 ◽

pp. vi320 ◽

Cited By ~ 1

Author(s):

M. Dreyling ◽

G. Krekeler ◽

A. Neuhof ◽

M. Woike ◽

G. Hess ◽

...

Keyword(s):

Clinical Practice ◽

Mantle Cell Lymphoma ◽

Cell Lymphoma ◽

Bendamustine as first-line treatment in patients with advanced indolent non-Hodgkin lymphoma and mantle cell lymphoma in German routine clinical practice

Annals of Hematology ◽

10.1007/s00277-015-2404-1 ◽

2015 ◽

Vol 94 (9) ◽

pp. 1553-1558 ◽

Cited By ~ 9

Author(s):

M. Becker ◽

B. Tschechne ◽

M. Reeb ◽

U. Schwinger ◽

H.-R. Bruch ◽

...

Keyword(s):

Clinical Practice ◽

Mantle Cell Lymphoma ◽

Hodgkin Lymphoma ◽

Cell Lymphoma ◽

Line Treatment ◽

First Line ◽

Non Hodgkin Lymphoma ◽

Mantle Cell ◽

First Line Treatment

EFFECTIVENESS AND SAFETY OF IBRUTINIB IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) AND MANTLE CELL LYMPHOMA (MCL) IN BELGIAN ROUTINE CLINICAL PRACTICE WITH A 3‐YEAR FOLLOW‐UP

Hematological Oncology ◽

10.1002/hon.20_2881 ◽

2021 ◽

Vol 39 (S2) ◽

Author(s):

A Janssens ◽

S Snauwaert ◽

D Bron ◽

Z Berneman ◽

F Offner ◽

...

Keyword(s):

Clinical Practice ◽

Chronic Lymphocytic Leukemia ◽

Mantle Cell Lymphoma ◽

Cell Lymphoma ◽

Lymphocytic Leukemia ◽

Evaluation of Safety, Tolerability and Efficacy of Temsirolimus in Patients with Relapsed or Refractory Mantle Cell Lymphoma (Rel/Refr Mcl) in Routine Clinical Practice

Annals of Oncology ◽

10.1093/annonc/mdu339.26 ◽

2014 ◽

Vol 25 ◽

pp. iv334

Author(s):

G. Krekeler ◽

M.H. Dreyling ◽

G. Hess ◽

D. Kalanovic

Keyword(s):

Clinical Practice ◽

Mantle Cell Lymphoma ◽

Cell Lymphoma ◽

3221 Evaluation of safety, tolerability and efficacy of Temsirolimus in patients with relapsed or refractory mantle cell lymphoma (rel/refr MCL) in routine clinical practice

European Journal of Cancer ◽

10.1016/s0959-8049(16)31798-1 ◽

2015 ◽

Vol 51 ◽

pp. S656

Author(s):

G. Krekeler ◽

A. Neuhof ◽

M. Dreyling ◽

G. Hess ◽

D. Kalanovic

Keyword(s):

Clinical Practice ◽

Mantle Cell Lymphoma ◽

Cell Lymphoma ◽

Evaluation of safety, tolerability and efficacy of temsirolimus in patients (pts) with relapsed or refractory mantle cell lymphoma (rel/refr MCL) in routine clinical practice

Annals of Oncology ◽

10.1093/annonc/mdx373.029 ◽

2017 ◽

Vol 28 ◽

pp. v365

Author(s):

M. Dreyling ◽

G. Hess ◽

G. Krekeler

Keyword(s):

Clinical Practice ◽

Mantle Cell Lymphoma ◽

Cell Lymphoma ◽

Treatment patterns among patients with mantle cell lymphoma and comparison of healthcare resource utilization and costs among relapsed/refractory patients treated with ibrutinib or chemoimmunotherapy: A real-world retrospective study

Clinical Therapeutics ◽

10.1016/j.clinthera.2021.06.012 ◽

2021 ◽

Author(s):

Nilanjan Ghosh ◽

Bruno Emond ◽

Marie-Hélène Lafeuille ◽

Aurélie Côté-Sergent ◽

Patrick Lefebvre ◽

...

Keyword(s):

Retrospective Study ◽

Mantle Cell Lymphoma ◽

Resource Utilization ◽

Real World ◽

Healthcare Resource ◽

Cell Lymphoma ◽

Healthcare Resource Utilization ◽

Treatment Patterns ◽